{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-014996","form_type":"8-K","ticker":"AYTU","cik":"0001385818","company_name":"AYTU BIOPHARMA, INC","filed_at":"2023-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.758214+00:00","generated_at":"2026-06-11T09:21:22.479145+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Aytu BioPharma approves $118K CEO bonus and $83K CFO bonus for 2023","bullets":["CEO Joshua R. Disbrow awarded $118,000 bonus (33% of target).","CFO Mark K. Oki awarded $83,000 bonus (50% of target).","Bonuses to be paid in January 2024; full payment if employment terminates early.","Approved by Compensation Committee on August 11, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-014996","json":"https://secwatch.observer/filing/0001558370-23-014996.json","markdown":"https://secwatch.observer/filing/0001558370-23-014996.md","text":"https://secwatch.observer/filing/0001558370-23-014996.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1385818/000155837023014996/0001558370-23-014996-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1385818/000155837023014996/aytu-20230811x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T09:21:22.479145+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}